DSIP — lyophilized powder · sterile vial
[ 01 · CATALOG · COGNITIVE PEPTIDES ]
In stock · ships within 24 h

DSIP

lyophilized powder · sterile vial

DSIP (Delta Sleep–Inducing Peptide) is a synthetic nonapeptide studied for its interaction with neuroendocrine and sleep-associated signaling pathways. It has been investigated in experimental models examining circadian regulation, hormonal modulation, and central nervous system signaling mechanisms.

C35H48N10O15 · MW 848.81 g/mol · CAS 62568-57-4

[ Pricing ] · Per vial · USD

Questions before you order?
Schedule 15 minutes to talk it through with the founder — no charge.

[ Quantity ]
View certificate
Purity (HPLC)
97.47%
Batch
Lot 1003
Verified by
MZ Biolabs
[ 02 · SPECIFICATIONS ]

What's in the vial.

Compound
DSIP (Delta Sleep-Inducing Peptide)
Sequence (1-letter)
WAGGDASGE
Molecular formula
C35H48N10O15
Molecular weight
848.81 g/mol
CAS number
62568-57-4
PubChem CID
68816
Vial size
15 mg net peptide
Form
Lyophilized powder
Purity (HPLC)
≥ 99% batch-verified
Storage — sealed
2–8 °C / room temp acceptable
Storage — reconstituted
2–8 °C / use within 60 days
Shelf life
36 months sealed, dark
[ 03 · CERTIFICATE OF ANALYSIS ]

Each batch, independently verified before release.

A third-party laboratory tests every batch by HPLC, mass spectrometry, and endotoxin assay. The certificate is tied to the lot number on the vial — not a generic safety document.

MZ Biolabs LLC

Independent third-party laboratory · Tucson, Arizona, USA · ISO 9001

VERIFIED 30 · MAR · 2026
Doc. 15004 Issued 30 Mar 2026
Compound DSIP
Batch / lot DSIP · Lot 1003
Net peptide 15 mg
Purity (HPLC) 97.47%
HPLC CHROMATOGRAM · 210.1–396.6 NM · UV DETECTION · RT 3.36 MIN · AREA 97.47% RT 3.36 min · area 97.47%
97.47%
0 min 3.36 min · main peak 30 min
Analyst:Ken Pendarvis, ChE Released:30 Mar 2026 Doc.15004
Reconstitution & Handling

Ships as lyophilized powder. Requires bacteriostatic water for reconstitution.

Operator-grade guides for the math, materials, and steps — without the guesswork.

[ 04 · LITERATURE ]

What the published research says.

Hedged scientific register. No therapeutic claims. Citations link to PubMed.

DSIP (Delta Sleep–Inducing Peptide) is a synthetic peptide studied in research on neuroendocrine signaling and circadian regulation pathways. Research has examined peptide-mediated central nervous system interactions.

Biochemical Characteristics

DSIP is a nine–amino acid peptide associated with neuroregulatory processes. Its structure supports investigation of peptide–receptor interactions within hypothalamic and pituitary signaling systems under experimental conditions.

Research Applications

DSIP is utilized in studies exploring circadian rhythm modulation, stress-related hormone signaling, and peptide-mediated neuroendocrine pathway regulation in controlled laboratory models.

Pathway / Mechanistic Context

Mechanistic research focuses on DSIP interaction with neuroendocrine signaling networks, including hypothalamic–pituitary axis pathways and regulatory feedback systems involved in sleep-associated processes.

Preclinical Research Summary

Studies have examined DSIP in cell culture and animal models, focusing on neuropeptide signaling behavior and endocrine modulation mechanisms.

Form & Analytical Testing

DSIP is supplied as a lyophilized peptide and undergoes analytical verification, including HPLC testing, to confirm identity, purity, and composition consistency for research use.

RUO Disclaimer

This product is intended strictly for research and laboratory use only. It is not approved for human consumption, medical treatment, veterinary use, cosmetic application, or diagnostic purposes. Handling should be performed only by qualified professionals trained in proper laboratory procedures.

Status of evidence. All published data referenced above is preclinical. This compound has not been approved by the FDA or any analogous regulatory body for any therapeutic indication. Researchers handling this compound should consult the primary literature directly.